238 related articles for article (PubMed ID: 10353730)
1. Receptor for interleukin 13 is a marker and therapeutic target for human high-grade gliomas.
Debinski W; Gibo DM; Hulet SW; Connor JR; Gillespie GY
Clin Cancer Res; 1999 May; 5(5):985-90. PubMed ID: 10353730
[TBL] [Abstract][Full Text] [Related]
2. An immune regulatory cytokine receptor and glioblastoma multiforme: an unexpected link.
Debinski W
Crit Rev Oncog; 1998; 9(3-4):255-68. PubMed ID: 10201630
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-13 receptor alpha2 chain: a potential biomarker and molecular target for ovarian cancer therapy.
Kioi M; Kawakami M; Shimamura T; Husain SR; Puri RK
Cancer; 2006 Sep; 107(6):1407-18. PubMed ID: 16902988
[TBL] [Abstract][Full Text] [Related]
4. Aberrant Stat3 signaling by interleukin-4 in malignant glioma cells: involvement of IL-13Ralpha2.
Rahaman SO; Vogelbaum MA; Haque SJ
Cancer Res; 2005 Apr; 65(7):2956-63. PubMed ID: 15805299
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-13 receptor alpha chain: a novel tumor-associated transmembrane protein in primary explants of human malignant gliomas.
Joshi BH; Plautz GE; Puri RK
Cancer Res; 2000 Mar; 60(5):1168-72. PubMed ID: 10728667
[TBL] [Abstract][Full Text] [Related]
6. Analysis of interleukin-13 receptor alpha2 expression in human pediatric brain tumors.
Kawakami M; Kawakami K; Takahashi S; Abe M; Puri RK
Cancer; 2004 Sep; 101(5):1036-42. PubMed ID: 15329913
[TBL] [Abstract][Full Text] [Related]
7. Specific recognition and killing of glioblastoma multiforme by interleukin 13-zetakine redirected cytolytic T cells.
Kahlon KS; Brown C; Cooper LJ; Raubitschek A; Forman SJ; Jensen MC
Cancer Res; 2004 Dec; 64(24):9160-6. PubMed ID: 15604287
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-13 receptor alpha2 chain in human head and neck cancer serves as a unique diagnostic marker.
Kawakami M; Kawakami K; Kasperbauer JL; Hinkley LL; Tsukuda M; Strome SE; Puri RK
Clin Cancer Res; 2003 Dec; 9(17):6381-8. PubMed ID: 14695138
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL
Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714
[TBL] [Abstract][Full Text] [Related]
10. In situ expression of interleukin-4 (IL-4) receptors in human brain tumors and cytotoxicity of a recombinant IL-4 cytotoxin in primary glioblastoma cell cultures.
Joshi BH; Leland P; Asher A; Prayson RA; Varricchio F; Puri RK
Cancer Res; 2001 Nov; 61(22):8058-61. PubMed ID: 11719427
[TBL] [Abstract][Full Text] [Related]
11. Combined effects of radiation and interleukin-13 receptor-targeted cytotoxin on glioblastoma cell lines.
Kawakami K; Kawakami M; Liu Q; Puri RK
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):230-7. PubMed ID: 16111594
[TBL] [Abstract][Full Text] [Related]
12. A bispecific immunotoxin (DTAT13) targeting human IL-13 receptor (IL-13R) and urokinase-type plasminogen activator receptor (uPAR) in a mouse xenograft model.
Todhunter DA; Hall WA; Rustamzadeh E; Shu Y; Doumbia SO; Vallera DA
Protein Eng Des Sel; 2004 Feb; 17(2):157-64. PubMed ID: 15047912
[TBL] [Abstract][Full Text] [Related]
13. Expression and structure of interleukin 4 receptors in primary meningeal tumors.
Puri S; Joshi BH; Sarkar C; Mahapatra AK; Hussain E; Sinha S
Cancer; 2005 May; 103(10):2132-42. PubMed ID: 15830341
[TBL] [Abstract][Full Text] [Related]
14. IL-13R(alpha)2, a decoy receptor for IL-13 acts as an inhibitor of IL-4-dependent signal transduction in glioblastoma cells.
Rahaman SO; Sharma P; Harbor PC; Aman MJ; Vogelbaum MA; Haque SJ
Cancer Res; 2002 Feb; 62(4):1103-9. PubMed ID: 11861389
[TBL] [Abstract][Full Text] [Related]
15. Analysis of antitumor activity of an interleukin-13 (IL-13) receptor-targeted cytotoxin composed of IL-13 antagonist and Pseudomonas exotoxin.
Kioi M; Kawakami K; Puri RK
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6231-8. PubMed ID: 15448012
[TBL] [Abstract][Full Text] [Related]
16. Potent antitumor activity of IL-13 cytotoxin in human pancreatic tumors engineered to express IL-13 receptor alpha2 chain in vivo.
Kawakami K; Kawakami M; Husain SR; Puri RK
Gene Ther; 2003 Jul; 10(13):1116-28. PubMed ID: 12808442
[TBL] [Abstract][Full Text] [Related]
17. Expression of a restrictive receptor for interleukin 13 is associated with glial transformation.
Debinski W; Slagle B; Gibo DM; Powers SK; Gillespie GY
J Neurooncol; 2000 Jun; 48(2):103-11. PubMed ID: 11083073
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 4 receptor-directed cytotoxin therapy for human head and neck squamous cell carcinoma in animal models.
Strome SE; Kawakami K; Alejandro D; Voss S; Kasperbauer JL; Salomao D; Chen L; Maki RA; Puri RK
Clin Cancer Res; 2002 Jan; 8(1):281-6. PubMed ID: 11801570
[TBL] [Abstract][Full Text] [Related]
19. Binding of interleukin-13 and interleukin-4 to the interleukin (IL)-4/IL-13 receptor of human synovial fibroblasts.
Lutz RA; Feng N; Moser R
J Recept Signal Transduct Res; 1999; 19(1-4):181-90. PubMed ID: 10071757
[TBL] [Abstract][Full Text] [Related]
20. Overexpressed cell surface interleukin-4 receptor molecules can be successfully targeted for antitumor cytotoxin therapy.
Kawakami K; Kawakami M; Puri RK
Crit Rev Immunol; 2001; 21(1-3):299-310. PubMed ID: 11642612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
